Publications

Cancer

Peterson EA, Jenkins EC, Lofgren KA, Chandiramani N, Liu H, Aranda E, Barnett M, Kenny PA. Amphiregulin is a critical downstream effector of estrogen signaling in ERα-positive breast cancer. Cancer Res. 2015;75(22):4830-4838. doi: 10.1158/0008-5472.CAN-15-0709. PMID: 26527289; PMCID: PMC4651747.

Azimi I, Beilby H, Davis FM, Marcial DL, Kenny PA, Thompson EW, Roberts-Thomson SJ, Monteith GR. Altered purinergic receptor-Ca²⁺ signaling associated with hypoxia-induced epithelial-mesenchymal transition in breast cancer cells. Mol Oncol. 2016;10(1):166-178. doi: 10.1016/j.molonc.2015.09.006. PMID: 26433470.

Chandiramani N, Kenny PA. Comparative analysis of GATA3 mutation profiles between Asian and Western patients with breast cancer. Is there really a difference? Cancer. 2014;120(17):2778-2779. doi: 10.1002/cncr.28782. PMID: 24898288.

So PL, Wang GY, Wang K, Chuang M, Chiueh VC, Kenny PA, Epstein EH Jr. PI3K-AKT signaling is a downstream effector of retinoid prevention of murine basal cell carcinogenesis. Cancer Prev Res (Phila). 2014;7(4):407-417. doi: 10.1158/1940-6207.CAPR-13-0304. PMID: 24449057; PMCID: PMC4046911.

Miwa HE, Koba WR, Fine EJ, Giricz O, Kenny PA, Stanley P. Bisected, complex N-glycans and galectins in mouse mammary tumor progression and human breast cancer. Glycobiology. 2013;23(12):1477-1490. doi: 10.1093/glycob/cwt075. PMID: 24037315; PMCID: PMC3816629.

Zhou ZN, Sharma VP, Beaty BT, Roh-Johnson M, Peterson EA, Van Rooijen N, Kenny PA, Wiley HS, Condeelis JS, Segall JE. Autocrine HBEGF expression promotes breast cancer intravasation, metastasis and macrophage-independent invasion in vivo. Oncogene. 2014;33(29):3784-3793. doi: 10.1038/onc.2013.363. PMID: 24013225; PMCID: PMC3950352.

Peterson EA, Pectasides E, Shabbeer S, Wiechmann L, Sparano JA, Kenny PA. Evaluation of serum Amphiregulin levels in breast cancer patients and cancer-free controls. Exp Hematol Oncol. 2013;2(1):25. doi: 10.1186/2162-3619-2-25. PMID: 24010672; PMCID: PMC3848366.

Giricz O, Calvo V, Peterson EA, Abouzeid CM, Kenny PA. TACE-dependent TGFα shedding drives triple-negative breast cancer cell invasion. Int J Cancer. 2013;133(11):2587-2595. doi: 10.1002/ijc.28295. PMID: 23729230; PMCID: PMC3966141.

Sparano JA, Ostrer H, Kenny PA. Translating genomic research into clinical practice: promise and pitfalls. Am Soc Clin Oncol Educ Book. 2013:15-23. doi:10.1200/EdBook_AM.2013.33.15. PMID: 23714445.

Curry MC, Peters AA, Kenny PA, Roberts-Thomson SJ, Monteith GR. Mitochondrial calcium uniporter silencing potentiates caspase-independent cell death in MDA-MB-231 breast cancer cells. Biochem Biophys Res Commun. 2013;434(3):695-700. doi: 10.1016/j.bbrc.2013.04.015. PMID: 23602897.

Calvo V, Kenny PA. Visualizing movement in the tumor microenvironment landscape. Breast Cancer Res. 2013;15(1):301. doi: 10.1186/bcr3359. PMID: 23320628; PMCID: PMC3672812.

Patsialou A, Wang Y, Lin J, Whitney K, Goswami S, Kenny PA, Condeelis JS. Selective gene-expression profiling of migratory tumor cells in vivo predicts clinical outcome in breast cancer patients. Breast Cancer Res. 2012;14(5):R139. doi: 10.1186/bcr3344. PMID: 23113900; PMCID: PMC4053118.

Levano KS, Kenny PA. Clarification of the C-terminal proteolytic processing site of human Amphiregulin. FEBS Lett. 2012;586(19):3500-3502. doi: 10.1016/j.febslet.2012.07.078. PMID: 22967896.

Lee SY, Meier R, Furuta S, Lenburg ME, Kenny PA, Xu R, Bissell MJ. FAM83A confers EGFR-TKI resistance in breast cancer cells and in mice. J Clin Invest. 2012;122(9):3211-3220. doi: 10.1172/JCI60498. PMID: 22886303; PMCID: PMC3428077.

Peters AA, Simpson PT, Bassett JJ, Lee JM, Da Silva L, Reid LE, Song S, Parat MO, Lakhani SR, Kenny PA, Roberts-Thomson SJ, Monteith GR. Calcium channel TRPV6 as a potential therapeutic target in estrogen receptor-negative breast cancer. Mol Cancer Ther. 2012;11(10):2158-2168. doi: 10.1158/1535 7163.MCT-11-0965. PMID: 22807578.

Curry MC, Luk NA, Kenny PA, Roberts-Thomson SJ, Monteith GR. Distinct regulation of cytoplasmic calcium signals and cell death pathways by different plasma membrane calcium ATPase isoforms in MDA-MB-231 breast cancer cells. J Biol Chem. 2012;287(34):28598-28608. doi: 10.1074/jbc.M112.364737. PMID: 22733819; PMCID: PMC3436507.

Peterson EA, Shabbeer S, Kenny PA. Normal range of serum Amphiregulin in healthy adult human females. Clin Biochem. 2012;45(6):460-463. doi: 10.1016/j.clinbiochem.2011.12.029. PMID: 22306169.

Giricz O, Calvo V, Pero SC, Krag DN, Sparano JA, Kenny PA. GRB7 is required for triple-negative breast cancer cell invasion and survival. Breast Cancer Res Treat. 2012;133(2):607-615. doi: 10.1007/s10549-011-1822-6. PMID: 22005836.

Giricz O, Reynolds PA, Ramnauth A, Liu C, Wang T, Stead L, Childs G, Rohan T, Shapiro N, Fineberg S, Kenny PA, Loudig O. Hsa-miR-375 is differentially expressed during breast lobular neoplasia and promotes loss of mammary acinar polarity. J Pathol. 2012;226(1):108-119. doi: 10.1002/path.2978. PMID: 21953071.

Sparano JA, Goldstein LJ, Childs BH, Shak S, Brassard D, Badve S, Baehner FL, Bugarini R, Rowley S, Perez EA, Shulman LN, Martino S, Davidson NE, Kenny PA, Sledge GW Jr, Gray R. Relationship between quantitative GRB7 RNA expression and recurrence after adjuvant anthracycline chemotherapy in triple-negative breast cancer. Clin Cancer Res. 2011;17(22):7194-7203. doi: 10.1158/1078-0432.CCR-10-3357. PMID: 21933890; PMCID: PMC3570203.

Davis FM, Kenny PA, Soo ET, van Denderen BJ, Thompson EW, Cabot PJ, Parat MO, Roberts-Thomson SJ, Monteith GR. Remodeling of purinergic receptor-mediated Ca2+ signaling as a consequence of EGF-induced epithelial-mesenchymal transition in breast cancer cells. PLoS One. 2011;6(8):e23464. doi: 10.1371/journal.pone.0023464. PMID: 21850275; PMCID: PMC3151299.

Levano KS, Jung EH, Kenny PA. Breast cancer subtypes express distinct receptor repertoires for tumor-associated macrophage derived cytokines. Biochem Biophys Res Commun. 2011;411(1):107-110. doi: 10.1016/j.bbrc.2011.06.102. PMID: 21712030.

Loudig O, Brandwein-Gensler M, Kim RS, Lin J, Isayeva T, Liu C, Segall JE, Kenny PA, Prystowsky MB. Illumina whole-genome complementary DNA-mediated annealing, selection, extension and ligation platform: assessing its performance in formalin-fixed, paraffin-embedded samples and identifying invasion pattern-related genes in oral squamous cell carcinoma. Hum Pathol. 2011;42(12):1911-1922. doi: 10.1016/j.humpath.2011.02.011. PMID: 21683979.

McAndrew D, Grice DM, Peters AA, Davis FM, Stewart T, Rice M, Smart CE, Brown MA, Kenny PA, Roberts-Thomson SJ, Monteith GR. ORAI1-mediated calcium influx in lactation and in breast cancer. Mol Cancer Ther. 2011;10(3):448-460. doi:10.1158/1535-7163.MCT-10-0923. PMID: 21224390.

Feng M, Grice DM, Faddy HM, Nguyen N, Leitch S, Wang Y, Muend S, Kenny PA, Sukumar S, Roberts-Thomson SJ, Monteith GR, Rao R. Store-independent activation of Orai1 by SPCA2 in mammary tumors. Cell. 2010;143(1):84-98. doi: 10.1016/j.cell.2010.08.040. PMID: 20887894; PMCID: PMC2950964.

Grice DM, Vetter I, Faddy HM, Kenny PA, Roberts-Thomson SJ, Monteith GR. Golgi calcium pump secretory pathway calcium ATPase 1 (SPCA1) is a key regulator of insulin-like growth factor receptor (IGF1R) processing in the basal-like breast cancer cell line MDA-MB-231. J Biol Chem. 2010;285(48):37458-37466. doi: 10.1074/jbc.M110.163329. PMID: 20837466; PMCID: PMC2988351.

Sparano JA, Fazzari M, Kenny PA. Clinical application of gene expression profiling in breast cancer. Surg Oncol Clin N Am. 2010;19(3):581-606. doi: 10.1016/j.soc.2010.03.008. PMID: 20620929.

Han J, Chang H, Giricz O, Lee GY, Baehner FL, Gray JW, Bissell MJ, Kenny PA, Parvin B. Molecular predictors of 3D morphogenesis by breast cancer cell lines in 3D culture. PLoS Comput Biol. 2010;6(2):e1000684. doi: 10.1371/journal.pcbi.1000684. PMID: 20195492; PMCID: PMC2829039.

Chen A, Cuevas I, Kenny PA, Miyake H, Mace K, Ghajar C, Boudreau A, Bissell MJ, Boudreau N. Endothelial cell migration and vascular endothelial growth factor expression are the result of loss of breast tissue polarity. Cancer Res. 2009;69(16):6721-6729. doi: 10.1158/0008-5472.CAN-08-4069. Erratum in: Cancer Res. 2010;70(15):6398. Bissell, Mina [corrected to Bissell, Mina

J]. PMID: 19654314; PMCID: PMC2760003.

Kenny PA, Lee GY, Myers CA, Neve RM, Semeiks JR, Spellman PT, Lorenz K, Lee EH, Barcellos-Hoff MH, Petersen OW, Gray JW, Bissell MJ. The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression. Mol Oncol. 2007;1(1):84-96. doi: 10.1016/j.molonc.2007.02.004. PMID: 18516279; PMCID: PMC2391005.

Faddy HM, Smart CE, Xu R, Lee GY, Kenny PA, Feng M, Rao R, Brown MA, Bissell MJ, Roberts-Thomson SJ, Monteith GR. Localization of plasma membrane and secretory calcium pumps in the mammary gland. Biochem Biophys Res Commun. 2008;369(3):977-981. doi: 10.1016/j.bbrc.2008.03.003. PMID: 18334228; PMCID: PMC3234104.

Kenny PA. Tackling EGFR signaling with TACE antagonists: a rational target for metalloprotease inhibitors in cancer. Expert Opin Ther Targets. 2007;11(10):1287-1298. PMID: 17907959.

Kenny PA. Three-dimensional extracellular matrix culture models of EGFR signalling and drug response. Biochem Soc Trans. 2007;35(Pt 4):665-668. PMID: 17635116.

Kenny PA. TACE: a new target in epidermal growth factor receptor dependent

tumors. Differentiation. 2007;75(9):800-808. PMID: 17608729.

McBryan J, Howlin J, Kenny PA, Shioda T, Martin F. ERalpha-CITED1 co-regulated genes expressed during pubertal mammary gland development: implications for breast cancer prognosis. Oncogene. 2007;26(44):6406-6419. PMID: 17486082.

Kenny PA, Lee GY, Bissell MJ. Targeting the tumor microenvironment. Front Biosci. 2007;12:3468-3474. PMID: 17485314; PMCID: PMC2841020.

Lee GY, Kenny PA, Lee EH, Bissell MJ. Three-dimensional culture models of normal and malignant breast epithelial cells. Nat Methods. 2007;4(4):359-365. PMID: 17396127; PMCID: PMC2933182.

Kenny PA, Bissell MJ. Targeting TACE-dependent EGFR ligand shedding in breast cancer. J Clin Invest. 2007;117(2):337-345. PMID: 17218988; PMCID: PMC1764856.

Radisky DC, Kenny PA, Bissell MJ. Fibrosis and cancer: do myofibroblasts come also from epithelial cells via EMT? J Cell Biochem. 2007 Jul 1;101(4):830-839. PMID: 17211838; PMCID: PMC2838476.

Bissell MJ, Kenny PA, Radisky DC. Microenvironmental regulators of tissue structure and function also regulate tumor induction and progression: the role of extracellular matrix and its degrading enzymes. Cold Spring Harb Symp Quant Biol. 2005;70:343-356. PMID: 16869771; PMCID: PMC3004779.

Fournier MV, Martin KJ, Kenny PA, Xhaja K, Bosch I, Yaswen P, Bissell MJ. Gene expression signature in organized and growth-arrested mammary acini predicts good outcome in breast cancer. Cancer Res. 2006;66(14):7095-7102. PMID: 16849555; PMCID: PMC2933218.

Kenny PA, Nelson CM, Bissell MJ. The ecology of tumors: by perturbing the microenvironment, wounds and infection may be key to tumor development. Scientist. 2006;20(4):30. PMID: 21132085; PMCID: PMC2995893.

Bascom JL, Kenny PA. Keystone symposium: the role of microenvironment in tumor induction and progression, Banff, Canada, 5-10 February 2005. Breast Cancer Res. 2005;7(3):113-118. PMID: 15987441; PMCID: PMC1143569.

Kenny PA, Enver T, Ashworth A. Receptor and secreted targets of Wnt-1/beta-catenin signalling in mouse mammary epithelial cells. BMC Cancer. 2005;5:3. PMID: 15642117; PMCID: PMC545969.

Kenny PA, Bissell MJ. Tumor reversion: correction of malignant behavior by microenvironmental cues. Int J Cancer. 2003;107(5):688-695. PMID: 14566816; PMCID: PMC2933180.

Kenny PA, Rizki A; American Society for Cell Biology. 42nd Annual Meeting of the American Society for Cell Biology, San Francisco, California, USA, 14-18 December 2002. Breast Cancer Res. 2003;5(3):147-153. PMID: 12793896; PMCID: PMC165005.

Kenny PA, Enver T, Ashworth A. Retroviral vectors for establishing tetracycline-regulated gene expression in an otherwise recalcitrant cell line. BMC Mol Biol. 2002;3:13. PMID: 12392602; PMCID: PMC126263.

Finlay-Jones JJ, Davies KV, Sturm LP, Kenny PA, Hart PH. Inflammatory processes in a murine model of intra-abdominal abscess formation. J Leukoc Biol. 1999;66(4):583-587. PMID: 10534113.

Kenny PA, Liston EM, Higgins DG. Molecular evolution of immunoglobulin and fibronectin domains in titin and related muscle proteins. Gene. 1999;232(1):11-23. PMID: 10333517.

Abdul-Majid KB, Kenny PA, Finlay-Jones JJ. The effect of the bacterial product, succinic acid, on neutrophil bactericidal activity. FEMS Immunol Med Microbiol. 1997;17(2):79-86. PMID: 9061353.

Kocher M, Kenny PA, Farram E, Abdul Majid KB, Finlay-Jones JJ, Geczy C L. Functional chemotactic factor CP-10 and MRP-14 are abundant in murine abscesses. Infect Immun. 1996;64(4):1342-1350. PMID: 8606099; PMCID: PMC173924.

Goodyear HM, Wilson P, Cropper L, Laidler PW, Sharp IR, Thaker U, Kenny PA, Price EH, Harper JI. Rapid diagnosis of cutaneous herpes simplex infections using specific monoclonal antibodies. Clin Exp Dermatol. 1994;19(4):294-297. PMID: 7955468.

Fu Q, Cash SE, Andersen JJ, Kennedy CR, Madadi AR, Raghavendra M, Dietrich LL, Agger WA, Shelley CS. Intracellular patterns of sialophorin expression define a new molecular classification of breast cancer and represent new targets for therapy. Br J Cancer. 2014;110(1):146-155. PMCID: PMC3887278.
Abstract

Fu Q, Cash SE, Andersen JJ, Kennedy CR, Oldenburg DG, Zander VB, Foley GR, Shelley CS. CD43 in the nucleus and cytoplasm of lung cancer is a potential therapeutic target. Int J Cancer. 2013;132(8):1761-1770.
Abstract

Cooper ST, Richters KE, Melin TE, Liu ZJ, Hordyk PJ, Benrud RR, Geiser LR, Cash SE, Shelley CS, Howard DR, Ereth MH, Sola-Visner MC. The hibernating 13-lined ground squirrel as a model organism for potential cold storage of platelets. Am J Physiol Regul Integr Comp Physiol. 2012;302(10):R1202-R1208. PMCID: PMC3362150.
Abstract

Microbiology

Lyme Disease

Lovrich SD, Jobe DA, Kowalski TJ, Policepatil SM, Callister SM. Expansion of the Midwestern focus for human granulocytic anaplasmosis into the region surrounding La Crosse, Wisconsin. J Clin Microbiol. 2011 Nov;49(11):3855-3859. PMCID: PMC3209085.
Abstract

Kuo J, Nardelli DT, Warner TF, Callister SM, Schell RF. Interleukin-35 enhances Lyme arthritis in Borrelia-vaccinated and -infected mice. Clin Vaccine Immunol. 2011 Jul;18(7):1125-1132. PMCID:PMC3147320.
Abstract

Jobe DA, Kowalski TJ, Bloemke M, Lovrich SD, Callister SM. Rapid decline of OspC borreliacidal antibodies following treatment of patients with early Lyme disease. Clin Vaccine Immunol. 2011 Jun;18(6):1034-1037. PMCID:PMC3122617.
Abstract

Nardelli DT, Luedtke JO, Munson EL, Warner TF, Callister SM, Schell RF. Significant differences between the Borrelia-infection and Borrelia-vaccination and -infection models of Lyme arthritis in C3H/HeN mice. FEMS Immunol Med Microbiol. 2010 Oct;60(1):78-89.
Abstract

LaFleur RL, Callister SM, Dant JC, Jobe DA, Lovrich SD, Warner TF, Wasmoen TL, Schell RF. One-year duration of immunity induced by vaccination with a canine Lyme disease bacterin. Clin Vaccine Immunol. 2010 May;17(5):870-874. PMCID: PMC2863397.
Abstract

Little SE, Heise SR, Blagburn BL, Callister SM, Mead PS. Lyme borreliosis in dogs and humans in the USA. Trends Parasitol. 2010 Apr;26(4):213-218.
Abstract

Nardelli DT, Munson EL, Callister SM, Schell RF. Human Lyme disease vaccines: past and future concerns. Future Microbiol. 2009 May;4(4):457-69.
Abstract

LaFleur RL, Dant JC, Wasmoen TL, Callister SM, Jobe DA, Lovrich SD, Warner TF, Abdelmagid O, Schell RF. Bacterin that induces anti-OspA and anti-OspC borreliacidal antibodies provides a high level of protection against canine Lyme disease. Clin Vaccine Immunol. 2009 Feb;16(2):253-259. PMCID: PMC2643534.
Abstract

Callister SM, Jobe DA, Schell RF. Detection of borreliacidal antibodies by flow cytometry. Curr Protoc Cytom. 2004 Nov;Chapter 11:Unit 11.5.
Abstract

Kotloski NJ, Nardelli DT, Peterson SH, Torrealba JR, Warner TF, Callister SM, Schell RF. Interleukin-23 is required for development of arthritis in mice vaccinated and challenged with Borrelia species. Clin Vaccine Immunol. 2008 Aug;15(8):1199-1207. PMCID: PMC2519303.
Abstract

Nardelli DT, Kevin Luk KH, Kotloski NJ, Warner TF, Torrealba JR, Callister SM, Schell RF. Role of IL-17, transforming growth factor-β, and IL-6 in the development of arthritis and production of anti-outer surface protein A borreliacidal antibodies in Borrelia-vaccinated and -challenged mice. FEMS Immunol Med Microbiol. 2008 Jul;53(2):265-274.
Abstract

Jobe DA, Lovrich SD, Asp KE, Mathiason MA, Albrecht SE, Schell RF, Callister SM. Significantly improved accuracy of diagnosis of early Lyme disease by peptide enzyme-linked immunosorbent assay based on the borreliacidal antibody epitope of Borrelia burgdorferi OspC. Clin Vaccine Immunol. 2008 Jun;15(6):981-985. PMCID: PMC2446615.
Abstract

Nardelli DT, Callister SM, Schell RF. Lyme arthritis: current concepts and a change in paradigm. Clin Vaccine Immunol. 2008 Jan;15(1):21-34. PMCID: PMC2223850.
Article

Peterson SH, Nardelli DT, Warner TF, Callister SM, Torrealba JR, Schell RF. Anti-p19 antibody treatment exacerbates Lyme arthritis and enhances borreliacidal activity. Clin Vaccine Immunol. 2007 May;14(5):510-517. PMCID: PMC1865634
Abstract

Lovrich SD, LaFleur RL, Jobe DA, Johnson JC, Asp KE, Schell RF, Callister SM. Borreliacidal OspC antibody response of canines with Lyme disease differs significantly from that of humans with Lyme disease. Clin Vaccine Immunol. 2007 May;14(5):635-637. PMCID: PMC1865635.
Abstract

Jobe DA, Nelson JA, Adam MD, Martin SA,Jr. Lyme disease in urban areas, Chicago. Emerg Infect Dis. 2007;13(11):1799-1800.
Link

Nardelli DT, Warner TF, Callister SM, Schell RF. Anti-CD25 antibody treatment of mice vaccinated and challenged with Borrelia spp. does not exacerbate arthritis but inhibits borreliacidal antibody production. Clin Vaccine Immunol. 2006 Aug; 13(8): 884-891. PMCID: PMC1539113.
Abstract

Jobe DA, Lovrich SD, Nelson JA, Velat TC, Anchor C, Koeune T, Martin SA,Jr. Borrelia burgdorferi in Ixodes scapularis ticks, Chicago area. Emerg Infect Dis. 2006 Jun;12(6):1039-1041.

Amlong CA, Nardelli DT, Peterson SH, Warner TF, Callister SM, Schell RF. Anti-interleukin-15 prevents arthritis in Borrelia-vaccinated and -infected mice. Clin Vaccine Immunol. 2006 Feb;13(2):289-296. PMCID: PMC1391944.
Abstract

Munson EL, Nardelli DT, Luk KH, Remington MC, Callister SM, Schell RF. Interleukin-6 promotes anti-OspA borreliacidal antibody production in vitro. Clin Vaccine Immunol. 2006 Jan;13(1):19-25. PMCID: PMC1356618.
Abstract

Nardelli DT, Cloute JP, Luk KH, Torrealba J, Warner TF, Callister SM, Schell RF. CD4(+) CD25(+) T cells prevent arthritis associated withBorrelia vaccination and infection. Clin Diagn Lab Immunol. 2005 Jun;12(6):786-792. PMCID: PMC1151965.
Abstract

Lovrich SD, Jobe DA, Schell RF, Callister SM. Borreliacidal OspC antibodies specific for a highly conserved epitope are immunodominant in human Lyme disease and do not occur in mice or hamsters. Clin Diagn Lab Immunol. 2005 Jun;12(6):746-751. PMCID: PMC1151971.
Abstract

Nardelli DT, Burchill MA, England DM, Torrealba J, Callister SM, Schell RF. Association of CD4+ CD25+ T cells with prevention of severe destructive arthritis in Borrelia burgdorferi-vaccinated and challenged gamma interferon-deficient mice treated with anti-interleukin-17 antibody. Clin Diagn Lab Immunol. 2004 Nov;11(6):1075-1084. PMCID: PMC524754.
Abstract

Munson EL, DeCoster DJ, Nardelli DT, England DM, Callister SM, Schell RF. Neutralization of gamma interferon augments borreliacidal antibody production and severe destructive Lyme arthritis in C3H/HeJ mice. Clin Diagn Lab Immunol. 2004 Jan;11(1):35-41. PMCID: PMC321347.
Abstract

Jobe DA, Lovrich SD, Schell RF, Callister SM. C-terminal region of outer surface protein C binds borreliacidal antibodies in sera from patients with Lyme disease. Clin Diagn Lab Immunol. 2003 Jul;10(4):573-578.
Abstract

Burchill MA, Nardelli DT, England DM, DeCoster DJ, Christopherson JA, Callister SM, Schell RF. Inhibition of interleukin-17 prevents the development of arthritis in vaccinated mice challenged with Borrelia burgdorferi. Infect Immun. 2003 Jun;71(6):3437-3442. PMCID: PMC155727.
Abstract

Christopherson JA, Munson EL, England DM, Croke CL, Remington MC, Molitor ML, DeCoster DJ, Callister SM, Schell RF. Destructive arthritis in vaccinated interferon gamma-deficient mice challenged with Borrelia burgdorferi: Modulation by tumor necrosis factor alpha. Clin Diagn Lab Immunol. 2003 Jan;10(1):44-52. PMCID: PMC145283.
Abstract

Munson EL, DuChateau BK, Jensen JR, Callister SM, DeCoster DJ, Schell RF. Gamma interferon inhibits production of anti-OspA borreliacidal antibody in vitro. Clin Diagn Lab Immunol. 2002 Sep;9(5):1095-1101. PMCID: PMC120068.
Abstract

Callister SM, Jobe DA, Agger WA, Schell RF, Kowalski TJ, Lovrich SD, Marks JA. Ability of the borreliacidal antibody test to confirm Lyme disease in clinical practice. Clin Diagn Lab Immunol. 2002 Jul;9(4):908-912. PMCID: PMC120016.
Abstract

Jackson CA, Lovrich SD, Agger WA, Callister SM. Reassessment of a midwestern Lyme disease focus for Borrelia burgdorferi and the human granulocytic ehrlichiosis agent. J Clin Microbiol. 2002 Jun;40(6):2070-2073. PMCID: PMC130725.
Abstract

Remington MC, Munson EL, Callister SM, Molitor ML, Christopherson JA, DeCoster DJ, Lovrich SD, Schell RF. Interleukin-6 enhances production of anti-OspC immunoglobulin G2b borreliacidal antibody. Infect Immun. 2001 Jul;69(7):4268-4275. PMCID: PMC98496.
Abstract

Callister SM, Jobe DA, Schell RF, Lovrich SD, Onheiber KL, Korshus JB. Detection of borreliacidal antibodies in dogs after challenge withBorrelia burgdorferi-infected Ixodes scapularis ticks. J Clin Microbiol. 2000 Oct;38(10):3670-3674. PMCID: PMC87454.
Abstract

Munson EL, DuChateau BK, Jobe DA, Lovrich SD, Callister SM, Schell RF. Production of borreliacidal antibody to outer surface protein A in vitro and modulation by interleukin-4. Infect Immun. 2000 Oct;68(10):5496-5501. PMCID: PMC101497.
Abstract

Croke CL, Munson EL, Lovrich SD, Christopherson JA, Remington MC, England DM, Callister SM, Schell RF. Occurrence of severe destructive Lyme arthritis in hamsters vaccinated with outer surface protein A and challenged with Borrelia burgdorferi. Infect Immun. 2000 Feb;68(2):658-663. PMCID: PMC97189.
Abstract

Wieneke CA, Lovrich SD, Callister SM, Jobe DA, Marks JA, Schell RF. Evaluation of whole-cell and OspC enzyme-linked immunosorbent assays for discrimination of early Lyme borreliosis from OspA vaccination. J Clin Microbiol. 2000 Jan;38(1):313-317. PMCID: PMC88715.
Abstract

Jobe DA, Rawal N, Schell RF, Callister SM. Detection of borreliacidal antibodies in Lyme borreliosis patient sera containing antimicrobial agents. Clin Diagn Lab Immunol. 1999 Nov;6(6):930-933. PMCID: PMC95800.
Abstract

DuChateau BK, Munson EL, England DM, Lovrich SD, Callister SM, Jensen JR, Schell RF. Macrophages interact with enriched populations of distinct T lymphocyte subsets for the induction of severe destructive Lyme arthritis. J Leukoc Biol. 1999 Feb;65(2):162-170.
Abstract

Rousselle JC, Callister SM, Schell RF, Lovrich SD, Jobe DA, Marks JA, Wieneke CA. Borreliacidal antibody production against outer surface protein C of Borrelia burgdorferi. J Infect Dis. 1998 Sep;178(3):733-741.
Abstract

Jensen JR, DuChateau BK, Munson EL, Callister SM, Schell RF. Inhibition of the production of anti-OspA borreliacidal antibody with T cells from hamsters vaccinated against Borrelia burgdorferi. Infect Immun. 1998 Apr;66(4):1507-1512. PMCID: PMC108081.
Abstract

Callister SM, Schell RF, Lovrich SD. Enhanced sensitivity of the borreliacidal-antibody test. Mayo Clin Proc. 1997 Nov;72(11):1093-1094 [Comment].

DuChateau BK, Jensen JR, England DM, Callister SM, Lovrich SD, Schell RF. Macrophages and enriched populations of T lymphocytes interact synergistically for the induction of severe, destructive Lyme arthritis. Infect Immun. 1997 Jul;65(7):2829-2836. PMCID: PMC175398.
Abstract

Bakken LL, Callister SM, Wand PJ, Schell RF. Interlaboratory comparison of test results for detection of Lyme disease by 516 participants in the Wisconsin State Laboratory of Hygiene/College of American Pathologists Proficiency Testing program. J Clin Microbiol. 1997 Mar;35(3):537-543. PMCID: PMC229622.
Abstract

Padilla ML, Callister SM, Schell RF, Bryant GL, Jobe DA, Lovrich SD, DuChateau BK, Jensen JR. Characterization of the protective borreliacidal antibody response in humans and hamsters after vaccination with a Borrelia burgdorferi outer surface protein A vaccine. J Infect Dis. 1996 Oct;174(4):739-746.
Abstract

Callister SM, Jobe DA, Schell RF, Pavia CS, Lovrich SD. Sensitivity and specificity of the borreliacidal-antibody test during early Lyme disease: A "gold standard"? Clin Diagn Lab Immunol. 1996 Jul;3(4):399-402. PMCID: PMC170357.
Abstract

DuChateau BK, England DM, Callister SM, Lim LC, Lovrich SD, Schell RF. Macrophages exposed to Borrelia burgdorferi induce Lyme arthritis in hamsters. Infect Immun. 1996 Jul;64(7):2540-2547. PMCID: PMC174108.
Abstract

Nicholls TH, Callister SM. Lyme disease spirochetes in ticks collected from birds in midwestern United States. J Med Entomol. 1996 May;33(3):379-384.
Abstract

Creson JR, Lim LC, Glowacki NJ, Callister SM, Schell RF. Detection of anti-Borrelia burgdorferi antibody responses with the borreliacidal antibody test, indirect fluorescent-antibody assay performed by flow cytometry, and western immunoblotting. Clin Diagn Lab Immunol. 1996 Mar;3(2):184-190. PMCID: PMC170272.
Abstract

Lovrich SD, Callister SM, DuChateau BK, Lim LC, Winfrey J, Day SP, Schell RF. Abilities of OspA proteins from different seroprotective groups of Borrelia burgdorferi to protect hamsters from infection. Infect Immun. 1995 Jun;63(6):2113-2119. PMCID: PMC173274.
Abstract

Callister SM, Schell RF. Importance of protective borreliacidal antibodies in Lyme disease immunity and serodiagnosis. J Infect Dis. 1994 Aug;170(2):499-500.

Lovrich SD, Callister SM, Lim LC, DuChateau BK, Schell RF. Seroprotective groups of Lyme borreliosis spirochetes from North America and Europe. J Infect Dis. 1994 Jul;170(1):115-121.
Abstract

Callister SM, Schell RF, Lim LC, Jobe DA, Case KL, Bryant GL, Molling PE. Detection of borreliacidal antibodies by flow cytometry. An accurate, highly specific serodiagnostic test for Lyme disease. Arch Intern Med. 1994 Jul 25;154(14):1625-1632.
Abstract

Lim LC, England DM, DuChateau BK, Glowacki NJ, Creson JR, Lovrich SD, Callister SM, Jobe DA, Schell RF. Development of destructive arthritis in vaccinated hamsters challenged with Borrelia burgdorferi. Infect Immun. 1994 Jul;62(7):2825-2833.
Abstract

Liu YF, Lim LC, Schell K, Lovrich SD, Callister SM, Schell RF. Differentiation of borreliacidal activity caused by immune serum or antimicrobial agents by flow cytometry. Clin Diagn Lab Immunol. 1994 Mar;1(2):145-149. PMCID: PMC368217.
Abstract

Jobe DA, Callister SM, Lim LC, Lovrich SD, Schell RF. Ability of canine Lyme disease vaccine to protect hamsters against infection with several isolates of Borrelia burgdorferi. J Clin Microbiol. 1994 Mar;32(3):618-622. PMCID: PMC263096.
Abstract

Lim LC, Liu YF, Schell K, Lovrich SD, Callister SM, Schell RF. Detection of borreliacidal antibody by using acridine orange and flow cytometry. Clin Diagn Lab Immunol. 1994 Jan;1(1):44-50. PMCID: PMC368194.
Abstract

Callister SM, Schell RF, Lovrich SD, Jobe DA. Lyme disease: laboratory diagnosis and serologic testing. Endeavour. 1994;18(2):80-84.
Abstract

Lovrich SD, Callister SM, Lim LC, Schell RF. Seroprotective groups among isolates of Borrelia burgdorferi. Infect Immun. 1993 Oct;61(10):4367-4374. PMCID: PMC281168.
Abstract

Jobe DA, Callister SM, Schell RF. Recovery of Borrelia burgdorferi by filtration. J Clin Microbiol. 1993 Jul;31(7):1896-1898. PMCID: PMC265653.
Abstract

Callister SM, Schell RF, Case KL, Lovrich SD, Day SP. Characterization of the borreliacidal antibody response to Borrelia burgdorferi in humans: A serodiagnostic test. J Infect Dis. 1993 Jan;167(1):158-164.
Abstract

Bakken LL, Case KL, Callister SM, Bourdeau NJ, Schell RF. Performance of 45 laboratories participating in a proficiency testing program for Lyme disease serology. JAMA. 1992 Aug 19;268(7):891-895.
Abstract

Agger WA, Callister SM, Jobe DA. In vitro susceptibilities of Borrelia burgdorferi to five oral cephalosporins and ceftriaxone. Antimicrob Agents Chemother. 1992 Aug;36(8):1788-1790. PMCID: PMC192050.
Abstract

Schmitz JL, Schell RF, Callister SM, Lovrich SD, Day SP, Coe JE. Immunoglobulin G2 confers protection against Borrelia burgdorferiinfection in LSH hamsters. Infect Immun. 1992 Jul;60(7):2677-2682. PMCID: PMC257220.
Abstract

Sachsenmeier KF, Schell K, Morrissey LW, Pennell DR, West RM, Callister SM, Schell RF. Detection of borreliacidal antibodies in hamsters by using flow cytometry. J Clin Microbiol. 1992 Jun;30(6):1457-1461. PMCID: PMC265310.
Abstract

Schmitz JL, Lovrich SD, Callister SM, Schell RF. Depletion of complement and effects on passive transfer of resistance to infection withBorrelia burgdorferi. Infect Immun. 1991 Oct;59(10):3815-3818. PMCID: PMC258956.
Abstract

Callister SM, Schell RF, Lovrich SD. Lyme disease assay which detects killed Borrelia burgdorferi. J Clin Microbiol. 1991 Sep;29(9):1773-1776. PMCID: PMC270208.
Abstract

Lovrich SD, Callister SM, Schmitz JL, Alder JD, Schell RF. Borreliacidal activity of sera from hamsters infected with the Lyme disease spirochete. Infect Immun. 1991 Aug;59(8):2522-2528. PMCID: PMC258050.
Abstract

Nelson JA, Bouseman JK, Kitron U, Callister SM, Harrison B, Bankowski MJ, Peeples ME, Newton BJ, Anderson JF. Isolation and characterization of Borrelia burgdorferi from Illinois Ixodes dammini. J Clin Microbiol. 1991 Aug;29(8):1732-1734. PMCID: PMC270194.
Abstract

Schmitz JL, Schell RF, Lovrich SD, Callister SM, Coe JE. Characterization of the protective antibody response to Borrelia burgdorferi in experimentally infected LSH hamsters. Infect Immun. 1991 Jun;59(6):1916-1921. PMCID: PMC257943.
Abstract

Agger WA, Case KL, Bryant GL, Callister SM. Lyme disease: Clinical features, classification, and epidemiology in the upper Midwest. Medicine (Baltimore). 1991 Mar;70(2):83-90.
Abstract

Callister SM, Nelson JA, Schell RF, Jobe DA, Bautz R, Agger WA, Coggins J. Survey for Ixodes spp. and Borrelia burgdorferi in southeastern Wisconsin and northeastern Illinois. J Clin Microbiol. 1991 Feb;29(2):403-406. PMCID: PMC269778.
Abstract

Callister SM, Case KL, Agger WA, Schell RF, Johnson RC, Ellingson JL. Effects of bovine serum albumin on the ability of Barbour-Stoenner-Kelly medium to detect Borrelia burgdorferi. J Clin Microbiol. 1990 Feb;28(2):363-365. PMCID: PMC269609.
Abstract

Hejka A, Schmitz JL, England DM, Callister SM, Schell RF. Histopathology of Lyme arthritis in LSH hamsters. Am J Pathol. 1989 May;134(5):1113-1123. PMCID: PMC1879892.
Abstract

Callister SM, Agger WA, Schell RF, Brand KM. Efficacy of the urinary bladder for isolation of Borrelia burgdorferi from naturally infected, wildPeromyscus leucopus. J Clin Microbiol. 1989 Apr;27(4):773-774. PMCID: PMC267416.
Abstract

Callister SM, Agger WA, Schell RF, Ellingson JL. Borrelia burgdorferi infection surrounding La Crosse, Wis. J Clin Microbiol. 1988 Dec;26(12):2632-2636. PMCID: PMC266960.
Abstract

Other Microorganisms

Agger WA, Siddiqui D, Lovrich SD, Merkitch KW, Callister SM, Borgert AJ, Mason TC, Baumgardner DJ, Burmester JK, Shukla S, Welter JD, Stewart SK, Washburn MJ, Bailey HH. Epidemiologic factors and urogenital infections associated with preterm birth in a Midwestern U.S. population. Obstet Gynecol. 2014;124(5):969-977. PMID: 25437726.
Abstract

Denys GA, Callister SM, Dowzicky MJ. Antimicrobial susceptibility among gram-negative isolates collected in the USA between 2005 and 2011 as part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.). Ann Clin Microbiol Antimicrob. 2013;12:24. PMID:24006892
Abstract

Schwan WR, Briska A, Stahl B, Wagner TK, Zentz E, Henkhaus J, Lovrich SD, Agger WA, Callister SM, DuChateau B, Dykes CW. Use of optical mapping to sort uropathogenic Escherichia coli strains into distinct subgroups. Microbiology. 2010;156(Pt 7):2124-2135.
Abstract

Fredricks BA, DeCoster DJ, Kim Y, Sparks N, Callister SM, Schell RF. Rapid pyrazinamide susceptibility testing of Mycobacterium tuberculosis by flow cytometry. J Microbiol Methods. 2006 Nov; 67(2): 266-272.
Abstract

Bly BL, Knutson MG, Sandheinrich MB, Gray BR, Jobe DA. Flow cytometry used to assess genetic damage in frogs from farm ponds. Journal of the Iowa Academy of Science. 2006;111(3-4):67-70.

DeCoster DJ, Vena RM, Callister SM, Schell RF. Susceptibility testing of Mycobacterium tuberculosis: Comparison of the BACTEC TB-460 method and flow cytometric assay with the proportion method. Clin Microbiol Infect. 2005 May;11(5):372-378.
Abstract

Schlicht MJ, Lovrich SD, Sartin JS, Karpinsky P, Callister SM, Agger WA. High prevalence of genital mycoplasmas among sexually active young adults with urethritis or cervicitis symptoms in La Crosse, Wisconsin. J Clin Microbiol. 2004;42:4636-4640. PMCID: PMC522307.
Abstract

Vena RM, Munson EL, DeCoster DJ, Croke CL, Fett DB, Callister SM, Schell RF. Flow cytometric testing of susceptibilities ofMycobacterium avium to amikacin, ciprofloxacin, clarithromycin and rifabutin in 24 hours. Clin Microbiol Infect. 2000 Jul;6(7):366-373.
Abstract

Moore AV, Kirk SM, Callister SM, Mazurek GH, Schell RF. Safe determination of susceptibility of Mycobacterium tuberculosis to antimycobacterial agents by flow cytometry. J Clin Microbiol. 1999 Mar;37(3):479-483.
Abstract

Schell RF, Callister SM, Kirk SM. Flow cytometric susceptibility testing of Mycobacterium tuberculosis. Am Clin Lab. 1998;17:24-25.

Kirk SM, Schell RF, Moore AV, Callister SM, Mazurek GH. Flow cytometric testing of susceptibilities of Mycobacterium tuberculosis isolates to ethambutol, isoniazid, and rifampin in 24 hours. J Clin Microbiol. 1998 Jun;36(6):1568-1573. PMCID: PMC104878.
Abstract

Schell RF, Callister SM, Kirk SM. Flow cytometric susceptibility testing of Mycobacterium tuberculosis. Am Clin Lab. 1998;17:24-25.

Kirk S M, Callister S M, Lim L C L, Schell R F. Rapid susceptibility testing of Candida albicans by flow cytometry. J Clin Microbiol. 1997;35:358-363.
Abstract

Norden MA, Kurzynski TA, Bownds SE, Callister SM, Schell RF. Rapid susceptibility testing of Mycobacterium tuberculosis (H37Ra) by flow cytometry. J Clin Microbiol. 1995 May;33(5):1231-1237.
Abstract

Callister SM, Agger WA. Enumeration and characterization of Aeromonas hydrophila and Aeromonas caviae isolated from grocery store produce. Appl Environ Microbiol. 1987 Feb;53(2):249-253.
Abstract

Agger WA, Callister SM. Intestinal infections with Aeromonas. Ann Intern Med. 1987 Mar;106(3):479. 

Callister S M, Winfrey M R. Microbial methylation of mercury in Upper Wisconsin River [USA] sediments. Water Air Soil Pollut. 1986;29:453-465.

Agger WA, TH Cogbill, H Busch, Jr, J Landercasper, SM Callister. 1986. Wounds caused by corn-harvesting machines: An unusual source of infection due to Gram-negative bacilli. Rev Infect Dis. 1986;8:927-931.
Abstract

Cancer

Fu Q, Cash SE, Anderson JJ, Kennedy CR, Oldenburg DG, Zander VB, Foley GB, Shelley CS. CD43 in the nucleus and cytoplasm of lung cancer is a potential therapeutic target. International Journal of Cancer. 2013;132(8):1761-1770.
Link

Go RS, Lee SJ, Shin D, Callister SM, Jobe DA, Conry RM, Tarhini AA, Kirkwood JM. ECOG Phase II trial of graded-dose peginterferon α-2b in patients with metastatic melanoma overexpressing basic fibroblast growth factor (E2602). Clin Cancer Res. 2013;19(23):6597-6604.19(23):6597-604. PMID:24122792.
Abstract

Pingali SR, Mathiason MA, Lovrich SD, Go RS. Emergence of chronic myelogenous leukemia from a background of myeloproliferative disorder: JAK2V617F as a potential risk factor for BCR-ABL translocation. Clin Lymphoma Myeloma. 2009;9:E25-29.
Abstract

Go RS, Jobe DA, Asp KE, Callister SM, Mathiason MA, Meyer LA, Bottner WA, Cole CE, Farnen JP, Frisby KA. Circulating endothelial cells in patients with chronic lymphocytic leukemia. Ann Hematol. 2008 May;87(5):369-373.
Abstract

Go RS, Lovrich SD, Callister SM, Meyer LA, Bottner WA, Farnen JP. Human cyclic thrombocytopenia and Anaplasma spp. infection. Eur J Haematol. 2005 Feb;74(2):182-183.

Patents

2012 – Early detection of canine Lyme disease by specific peptides and antibodies (#8,313,915)

2012 – Canine Lyme disease vaccine (#8,137,678)

2001 – Compositions and methods using the borreliacidal epitope of Borrelia burgdorferi outer surface protein C for the diagnosis and prevention of Lyme disease (#6,210,676)

2001 – Borrelia burgdorferi bacterin (#6,316,005)

1995 - Diagnostic assay for Lyme disease (#5,385,826)

Rheumatology

Mandal P, Krueger BE, Oldenburg D, Andry KA, Beard RS, White DW, Barton ES. A gammaherpesvirus cooperates with interferon-alpha/beta-induced IRF2 to halt viral replication, control reactivation, and minimize host lethality. PLoS Pathog. 2011 Nov;7(11):e1002371. PMCID: PMC3219715.
Link

White DW, Keppel CR, Schneider SE, Reese TA, Coder J, Payton JE, Ley TJ, Virgin HW, Fehniger TA. Latent herpesvirus infection arms NK cells. Blood. 2010 Jun 3;115(22):4377-4383. PMCID: PMC2881492. 
Link

Eash KJ, Means JM, White DW, Link DC. CXCR4 is a key regulator of neutrophil release from the bone marrow under basal and stress granulopoiesis conditions. Blood. 2009 May 7;113(19):4711-4719. PMCID: PMC2680371.
Link

Tarakanova VL, Kreisel F, White DW, Virgin HW,4th. Murine gammaherpesvirus 68 genes both induce and suppress lymphoproliferative disease. J Virol. 2008 Jan;82(2):1034-1039. PMCID: PMC2224605. 
Link

Weinberg A, Spritzler J, Nokta M, Schrier R, Landay A, Brown D, Pollard R. In vitro cell-mediated immune responses of human immunodeficiency virus-infected and -uninfected individuals to whole cytomegalovirus antigens and their subunits. Clinical and Vaccine Immunology. 2008 June;15(9):1398-1409. PMCID: PMC2546686.
Link

Barton ES, White DW, Cathelyn JS, Brett-McClellan KA, Engle M, Diamond MS, Miller VL, Virgin HW,4th. Herpesvirus latency confers symbiotic protection from bacterial infection. Nature. 2007 May 17;447(7142):326-329.
Abstract


Invited Reviews

White DW, Beard RS, Barton ES.Immune modulation during latent herpesvirus infection. Immunol Rev. 2012 Jan;245(1):189-208.
Abstract

Barton ES, White DW. (C)Re-combining textbook models of virus spread within the host. Cell Host Microbe. 2008 Apr 17;3(4):201-202.
Abstract

Harty JT, Tvinnereim AR, White DW. CD8+ T cell effector mechanisms in resistance to infection. Annu Rev Immunol. 2000;18:275-308. 
Abstract

Love + Medicine

Every day, Gundersen Health System delivers great medicine plus a little something extra—we call it Love + Medicine.

Share Your Story